Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
30%
OVERLAP
BY WEIGHT
45
# OF OVERLAPPING
HOLDINGS
BTEE.L
272
HOLDINGS
20%
ALSO IN XGEN.DE
XGEN.DE
100
HOLDINGS
48%
ALSO IN BTEE.L
SECTOR DRIFT (BTEE.L minus XGEN.DE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BTEE.L |
Weight in XGEN.DE |
Overlap | |
|---|---|---|---|---|
 |
VERTEX PHARMACEUTICALS INC | 8.7% | 4.4% | 4.4% |
|
INSMED INC | 2.5% | 3.5% | 2.5% |
|
ALNYLAM PHARMACEUTICALS INC | 3.6% | 2.4% | 2.4% |
 |
ARGENX SE ADR | 1.8% | 3.1% | 1.8% |
|
ILLUMINA INC | 1.8% | 4.3% | 1.8% |
BTEE.L Overweight Relative to XGEN.DE
|
GILEAD SCIENCES INC | 8.4% |
|
AMGEN INC | 8.1% |
|
REGENERON PHARMACEUTICALS | 5.8% |
|
VERTEX PHARMACEUTICALS INC | 4.3% |
|
BIOGEN IDEC INC | 1.9% |
|
REVOLUTION MEDICINES, INC. | 1.7% |
|
INCYTE CORP | 1.5% |
|
UNITED THERAPEUTICS CORP | 1.5% |
|
ROYALTY PHARMA PLC CLASS A | 1.3% |
|
ALNYLAM PHARMACEUTICALS INC | 1.2% |
BTEE.L Underweight Relative to XGEN.DE
|
NATERA INC | -5.0% |
 |
ROCHE HOLDING AG-GENUSSCHEIN | -4.9% |
|
ROCHE HOLDING LTD | -4.9% |
|
DANAHER CORP | -4.7% |
|
ELI LILLY & CO | -4.4% |
|
LONZA GROUP AG-REG | -4.4% |
|
ABBOTT LABORATORIES | -4.1% |
|
AGILENT TECHNOLOGIES INC | -4.1% |
 |
WUXI BIOLOGICS (CAYMAN) INC. | -2.7% |
|
PERKINELMER INC | -2.6% |